Sign In

Kevin Bitterman

Partner at Atlas Venture

Kevin Bitterman is a partner at Atlas Venture and serves on the Board of Directors of Mariana Oncology.4 He focuses on creating and investing in companies that translate groundbreaking science into innovative medicines.1

Bitterman holds a Ph.D. in Genetics from Harvard Medical School and a BA in Biology from Rutgers University.12 His extensive experience in the biotechnology and pharmaceutical industry includes:

  1. Founding CEO roles at Editas Medicine, Morphic Therapeutic, and Visterra.12
  2. Board positions at several companies, including Disc Medicine, Chroma Medicine, Remix Therapeutics, and Kinaset Therapeutics.12
  3. Previous partnership at Polaris Partners from 2004 to 2017.12

In addition to his role at Mariana Oncology, Bitterman is involved with various organizations:

  • Member of the Harvard Medical School Blavatnik Biomedical Accelerator and BTCA Steering Committees.1
  • Member of the Isabella Stuart Gardner Museum Board of Advisors.12
  • Previously served as a board member for companies like Akero Therapeutics, Vedere Bio, and Taris Biomedical.1

Bitterman has been instrumental in Mariana Oncology's development, including its $75 million Series A funding in December 2021 to advance its multimodal pipeline of precision radiopharmaceuticals for solid tumors.3

Related Questions

What are Kevin Bitterman's main responsibilities at Mariana Oncology?
How did Kevin Bitterman's career evolve from his time at Polaris Partners to Atlas Venture?
What are some of the notable companies Kevin Bitterman has served on the board of?
How has Kevin Bitterman's background in genetics influenced his work in biotech?
What are the key achievements of Kevin Bitterman at Atlas Venture?
Kevin Bitterman
Kevin Bitterman, photo 1
Kevin Bitterman, photo 2
Add to my network

Location

Cambridge, Massachusetts, United States